Cite
HARVARD Citation
Wakabayashi, Y. et al. (2021). Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer. Cancer science. 112 (1), pp. 369-379. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wakabayashi, Y. et al. (2021). Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer. Cancer science. 112 (1), pp. 369-379. [Online].